Chester County biopharmaceutical company Trevena Inc. is cutting 21 jobs and halting its investments in early-stage research under a restructuring to focus its resources on its lead new drug candidate.
The workforce reduction represents 30 percent of the Chesterbook, Pa., company's staff. Among those leaving is Michael Lark, the company's chief scientific officer, who will depart in mid-December.
Trevena's immediate focus will be on the potential approval and commercialization of Olinvo, its new…
Chester County biopharmaceutical company Trevena Inc. is cutting 21 jobs and halting its investments in early-stage research under a restructuring to focus its resources on its lead new drug candidate.
The workforce reduction represents 30 percent of the Chesterbook, Pa., company's staff. Among those leaving is Michael Lark, the company's chief scientific officer, who will depart in mid-December.
Trevena's immediate focus will be on the potential approval and commercialization of Olinvo, its new…